LifePoint Health, Inc. (NASDAQ:LPNT) – Equities research analysts at KeyCorp decreased their Q3 2017 earnings estimates for LifePoint Health in a research note issued on Thursday. KeyCorp analyst J. Gurda now forecasts that the company will earn $0.92 per share for the quarter, down from their previous forecast of $0.99. KeyCorp also issued estimates for LifePoint Health’s Q4 2017 earnings at $1.17 EPS and FY2017 earnings at $4.11 EPS.

LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.06. The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The firm’s revenue for the quarter was up .2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.69 earnings per share.

TRADEMARK VIOLATION NOTICE: This piece was first reported by American Banking News and is the property of of American Banking News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/08/07/q3-2017-earnings-estimate-for-lifepoint-health-inc-issued-by-keycorp-nasdaqlpnt.html.

Several other research analysts also recently weighed in on LPNT. BidaskClub downgraded LifePoint Health from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 price target for the company in a report on Thursday, July 13th. Royal Bank Of Canada reiterated a “buy” rating and issued a $77.00 price target on shares of LifePoint Health in a report on Wednesday, July 5th. Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $73.00 to $74.00 in a report on Tuesday, June 6th. Finally, Morgan Stanley began coverage on LifePoint Health in a report on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 price target for the company. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the stock. LifePoint Health has a consensus rating of “Hold” and an average price target of $66.18.

LifePoint Health (NASDAQ:LPNT) opened at 58.45 on Monday. The company has a 50-day moving average price of $64.73 and a 200 day moving average price of $62.97. The stock has a market capitalization of $2.34 billion, a price-to-earnings ratio of 13.09 and a beta of 0.86. LifePoint Health has a 12 month low of $50.60 and a 12 month high of $70.95.

In other news, Chairman William F. Carpenter III sold 82,347 shares of the company’s stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the completion of the sale, the chairman now directly owns 504,535 shares in the company, valued at approximately $32,365,920.25. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Chairman William F. Carpenter III sold 17,653 shares of the company’s stock in a transaction on Monday, July 17th. The stock was sold at an average price of $65.06, for a total value of $1,148,504.18. Following the sale, the chairman now owns 439,841 shares of the company’s stock, valued at $28,616,055.46. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 102,000 shares of company stock valued at $6,556,824. Insiders own 7.28% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in LPNT. BlackRock Inc. increased its stake in LifePoint Health by 11,671.9% in the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock worth $245,351,000 after buying an additional 3,714,004 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in LifePoint Health by 0.5% in the first quarter. Dimensional Fund Advisors LP now owns 3,388,830 shares of the company’s stock worth $221,969,000 after buying an additional 18,327 shares during the last quarter. Vanguard Group Inc. increased its stake in LifePoint Health by 3.8% in the first quarter. Vanguard Group Inc. now owns 3,266,963 shares of the company’s stock worth $213,986,000 after buying an additional 120,201 shares during the last quarter. Wellington Management Group LLP increased its stake in LifePoint Health by 5.5% in the first quarter. Wellington Management Group LLP now owns 3,257,272 shares of the company’s stock worth $213,351,000 after buying an additional 168,451 shares during the last quarter. Finally, Alliancebernstein L.P. increased its stake in LifePoint Health by 4.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,943 shares of the company’s stock worth $113,049,000 after buying an additional 68,886 shares during the last quarter. Institutional investors and hedge funds own 98.75% of the company’s stock.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.